Stimulation of the topoisomerase II induced DNA cleavage sites in the c-myc protooncogene by antitumor drugs is associated with gene expression - PubMed (original) (raw)
. 1989 Nov 14;28(23):9104-10.
doi: 10.1021/bi00449a022.
Affiliations
- PMID: 2557917
- DOI: 10.1021/bi00449a022
Stimulation of the topoisomerase II induced DNA cleavage sites in the c-myc protooncogene by antitumor drugs is associated with gene expression
J F Riou et al. Biochemistry. 1989.
Abstract
The antitumor drugs mAMSA and VM26 were shown to stimulate the topoisomerase II (Topo II) cleavage activity on the c-myc protooncogene in several human tumor cell lines (N417, HL60, EJ, H146, CaSki, A431, IGROV1, and CAL18A) and human peripheral lymphocytes. The mAMSA-induced gene cleavage was found to increase with the steady-state levels of c-myc transcripts in cell lines while no cleavage could be evidenced in the other genes so far tested. In mAMSA-treated N417 cells, the overall genomic DNA cleavage detected by alkaline elution was found to be about 20 times lower than the c-myc gene cleavage. Topo II mRNA levels were associated with the nuclear Topo II decatenating activity in cell lines and increased with c-myc cleavage. Topo II decatenating activity was found to be 3 times lower in quiescent than in exponentially growing N417 cells, but the c-myc cleavage induced by mAMSA was found as intense in quiescent as in growing cells. Thus, our data seem to indicate that c-myc gene cleavage is not related to cellular Topo II content but rather to c-myc gene transcription. Therefore, we suggest that only a small fraction of the Topo II is able to react with drug on the c-myc gene in relation to its transcriptional accessibility. Since c-myc overexpression is frequently found to be related to human cancer progression, we suggest that this gene could be an important target for Topo II related antitumor drugs.
Similar articles
- In vivo and in vitro stimulation by antitumor drugs of the topoisomerase II-induced cleavage sites in c-myc proto-oncogene.
Riou JF, Vilarem MJ, Larsen CJ, Multon E, Riou GF. Riou JF, et al. NCI Monogr. 1987;(4):41-7. NCI Monogr. 1987. PMID: 2819730 - In vivo stimulation by antitumor drugs of the topoisomerase II induced cleavage sites in c-myc protooncogene.
Riou JF, Multon E, Vilarem MJ, Larsen CJ, Riou G. Riou JF, et al. Biochem Biophys Res Commun. 1986 May 29;137(1):154-60. doi: 10.1016/0006-291x(86)91189-7. Biochem Biophys Res Commun. 1986. PMID: 3013177 - Topoisomerase II-mediated DNA cleavage activity induced by ellipticines on the human tumor cell line N417.
Multon E, Riou JF, LeFevre D, Ahomadegbe JC, Riou G. Multon E, et al. Biochem Pharmacol. 1989 Jul 1;38(13):2077-86. doi: 10.1016/0006-2952(89)90060-9. Biochem Pharmacol. 1989. PMID: 2544183 - Differential effects of amsacrine and epipodophyllotoxins on topoisomerase II cleavage in the human c-myc protooncogene.
Pommier Y, Orr A, Kohn KW, Riou JF. Pommier Y, et al. Cancer Res. 1992 Jun 1;52(11):3125-30. Cancer Res. 1992. PMID: 1317259
Cited by
- Transcriptional consequences of topoisomerase inhibition.
Collins I, Weber A, Levens D. Collins I, et al. Mol Cell Biol. 2001 Dec;21(24):8437-51. doi: 10.1128/MCB.21.24.8437-8451.2001. Mol Cell Biol. 2001. PMID: 11713279 Free PMC article. - DNA topoisomerase II sites in the histone H4 gene during the highly synchronous cell cycle of Physarum polycephalum.
Borde V, Duguet M. Borde V, et al. Nucleic Acids Res. 1998 May 1;26(9):2042-49. doi: 10.1093/nar/26.9.2042. Nucleic Acids Res. 1998. PMID: 9547257 Free PMC article. - Multiple single-stranded cis elements are associated with activated chromatin of the human c-myc gene in vivo.
Michelotti GA, Michelotti EF, Pullner A, Duncan RC, Eick D, Levens D. Michelotti GA, et al. Mol Cell Biol. 1996 Jun;16(6):2656-69. doi: 10.1128/MCB.16.6.2656. Mol Cell Biol. 1996. PMID: 8649373 Free PMC article. - DNA topoisomerase I and II in cancer chemotherapy: update and perspectives.
Pommier Y. Pommier Y. Cancer Chemother Pharmacol. 1993;32(2):103-8. doi: 10.1007/BF00685611. Cancer Chemother Pharmacol. 1993. PMID: 8387398 Review. No abstract available. - Multilevel therapeutic targeting by topoisomerase inhibitors.
Smith PJ, Souès S. Smith PJ, et al. Br J Cancer Suppl. 1994 Sep;23:S47-51. Br J Cancer Suppl. 1994. PMID: 8075006 Free PMC article. Review.